Marinomed Biotech AG Stock
Marinomed Biotech AG gained 0.270% compared to yesterday.
The community is currently still undecided about Marinomed Biotech AG with 0 Buy predictions and 1 Sell predictions.
A target price of 2 € results in a potential of -89.04% which would mean heavy losses compared to the current price of 18.25 € for Marinomed Biotech AG.
Our community identified positive and negative aspects for Marinomed Biotech AG stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Marinomed Biotech AG stock. On the other hand our users think that "Expected dividend yield" could be a problem in the future.
Pros and Cons of Marinomed Biotech AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
EQS-Adhoc: Marinomed Biotech AG begins reviewing strategic options for the Marinosolv platform
EQS-News: Marinomed Biotech AG announces results for the first half year of 2025
EQS-News: Marinomed Biotech AG announces results for the first half year of 2025
EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share
EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 61.607 no-par value bearer shares at an issue price of EUR 17,50 per share